SOPH
Sophia Genetics SA
NASDAQ: SOPH · HEALTHCARE · HEALTH INFORMATION SERVICES
$5.28
+5.60% today
Updated 2026-04-29
Market cap
$358.34M
P/E ratio
—
P/S ratio
4.64x
EPS (TTM)
$-1.17
Dividend yield
—
52W range
$3 – $6
Volume
0.1M
Sophia Genetics SA (SOPH) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-31.68M | $-31.73M | $-57.94M | $-70.09M | $-48.58M | $-42.82M | $-38.01M |
| Capital expenditures | $3.03M | $3.20M | $6.67M | $10.38M | $9.23M | $8.18M | $574000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $717000.00 | $1.36M | $8.51M | $13.61M | $15.24M | $16.49M | $16.20M |
| Free cash flow | $-34.71M | $-34.93M | $-64.61M | $-80.47M | $-57.80M | $-51.00M | $-38.59M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |